Warmer temperatures lessen COVID-19 spread, but control measures still needed

10-Jun-2021 9:00 AM EDT, by Imperial College London

Newswise — New research shows transmission of the virus behind COVID-19 varies seasonally, but warmer conditions are not enough to prevent transmission.

The study, led by Imperial College London researchers and published today in Proceedings of the National Academy of Sciences, is the first to incorporate environmental data into epidemiological models of the transmission of SARS-CoV-2, the virus behind COVID-19.

The team show that temperature and population density are the most important factors determining how easily the virus spreads, but only in the absence of mobility-restricting measures, such as lockdowns.

First author of the study Dr Tom Smith, from the Department of Life Sciences at Imperial, said: "Our results show that temperature changes have a much smaller effect on transmission than policy interventions, so while people remain unvaccinated, governments mustn't drop policies like lockdowns and social distancing just because a seasonal change means the weather is warming up.

"However, our work also suggests that lower autumn and winter temperatures may lead to the virus spreading more easily in the absence of policy interventions or behavioural changes."

Seasonal variation has been a source of uncertainty in forecasts of SARS-CoV-2 transmission. Other viruses, like flu viruses and other coronaviruses, are known to be affected by environmental factors. For example, high temperatures and low humidity reduce the transmission of respiratory droplets, preventing the spread of flu. High temperatures are also known to inactivate other coronaviruses in the air and on surfaces.

However, quantifying the effects of environmental factors including temperature, humidity, and UV radiation (sunshine) on SARS-CoV-2 transmission has been difficult during the pandemic, since human factors like population density and behaviour have been the main drivers of transmission.

The differences in interventions and case-counting between countries and regions also makes comparing environmental factors on a global scale difficult, especially as some countries, like Brazil, India and Iran, have high transmission despite having warmer climates.

As a result, few epidemiological models have included environmental data, and those that do assume the response of SARS-CoV-2 is identical to other coronaviruses, as there is a lack of SARS-CoV-2-specific data.

To fill this gap, the team, from the Departments of Life Sciences and Mathematics at Imperial, as well as Imperial's MRC Centre for Global Infectious Disease Analysis, and Utah State University, compared transmission across the USA. The country has a large range of climates with comparable policies and case numbers, allowing the impact of environmental factors to be teased out.

They found strong evidence that lower temperature and higher population density are both associated with higher SARS-CoV-2 transmission.

Lead researcher Dr Will Pearse, from the Department of Life Sciences at Imperial, said: "While temperature and population density do influence SARS-CoV-2 transmission, our findings re-confirm that the most important drivers are public policy and individual behaviour. For example, during lockdowns, there was no meaningful signature of temperature influencing transmission.

"This means, for example, that warmer regions should not expect to ease mobility restrictions before colder regions. This is especially true as warmer regions tend to have higher population densities - for example, the population in Florida is more densely packed than in Minnesota."

The researchers are now extending their study to new variants, and say their environmental results should be incorporated into future forecasts to enhance predictions of disease spread.

Study co-author Dr Ilaria Dorigatti, from the MRC Centre for Global Infectious Disease Analysis at Imperial, said: "We found evidence that, in the early phases of the pandemic, places with colder temperatures were associated with higher SARS-CoV-2 transmission intensities. However, the effect of climatic seasonality on SARS-CoV-2 transmission is weaker than the effect of population density and in turn, of policy interventions.

"This implies that, as we move towards summer in the Northern Hemisphere, public health policy decisions remain of critical importance for epidemic control and adherence to recommendations will continue to play a key role against SARS-CoV-2 transmission."

###

SEE ORIGINAL STUDY



Filters close

Showing results

110 of 6075
Newswise: Don’t Let the Raging Virus Put Life in Jeopardy. Chula Recommends How to Build an Immunity for Your Heart Against Stress and Depression
Released: 28-Jul-2021 8:55 AM EDT
Don’t Let the Raging Virus Put Life in Jeopardy. Chula Recommends How to Build an Immunity for Your Heart Against Stress and Depression
Chulalongkorn University

Cumulative stress, denial, and chronic depression are the byproducts of the COVID-19 pandemic. The Center for Psychological Wellness, Chulalongkorn University recommends ways to cope by harnessing positive energy from our heart.

Newswise: Connect Chicago Initiative Expands Community COVID-19 Testing
Released: 27-Jul-2021 4:45 PM EDT
Connect Chicago Initiative Expands Community COVID-19 Testing
Rush University Medical Center

As COVID-19 cases rise in the U.S., Connect Chicago — new initiative between the Chicago Department of Public Health, Rush University Medical Center, and Esperanza Health Centers — is aiming to redouble testing efforts in Chicago communities that need it most.

Newswise: California State University to Implement COVID-19 Vaccination Requirement for Fall 2021 Term
Released: 27-Jul-2021 1:35 PM EDT
California State University to Implement COVID-19 Vaccination Requirement for Fall 2021 Term
California State University (CSU) Chancellor's Office

California State University to Implement COVID-19 Vaccination Requirement for Fall 2021 Term

Released: 27-Jul-2021 12:55 PM EDT
Behind the COVID-19 Diagnostic for Testing Hundreds of People at a Time
The Fannie and John Hertz Foundation

Hertz Fellow Cameron Myhrvold and colleagues are advancing research that started long before the pandemic.

Released: 27-Jul-2021 12:35 PM EDT
T cell response not critical for immune memory to SARS-CoV-2 or recovery from COVID-19
American Society for Microbiology (ASM)

New research conducted in monkeys reveals that T cells are not critical for the recovery of primates from acute COVID-19 infections.

Released: 27-Jul-2021 11:45 AM EDT
mRNA Vaccinations vs COVID-19 Risk in Teens – Vaccinations are Safer
Case Western Reserve University

Case Western Reserve University researchers have demonstrated that the risk for myocarditis/pericarditis (heart inflammation) among male teens (12-17) diagnosed with COVID-19 is nearly 6 times higher than their combined risk following first and second doses of an mRNA COVID-19 vaccination. The risk for myocarditis/pericarditis among girls (ages 12-17) is 21 times greater from COVID-19 than from vaccines.

Released: 27-Jul-2021 9:45 AM EDT
Twitter Study Tracks Early Days of COVID-19 Pandemic in U.S.
Binghamton University, State University of New York

Researchers at Binghamton University, State University of New York studied Twitter communications to understand the societal impact of COVID-19 in the United States during the early days of the pandemic.

Released: 27-Jul-2021 9:45 AM EDT
A First Report of COVID-19 Orbital Involvement Is Reported in the Journal of Craniofacial Surgery
Wolters Kluwer Health: Lippincott

A severe skin infection in the orbital area (around the eye) may represent an unusual complication of COVID-19, according to a patient report published in The Journal of Craniofacial Surgery. The journal is published in the Lippincott portfolio by Wolters Kluwer.

Newswise: “Baiya Vaccine” from Chula — a Testament of Thai Mastery — Coming this September
Released: 27-Jul-2021 8:55 AM EDT
“Baiya Vaccine” from Chula — a Testament of Thai Mastery — Coming this September
Chulalongkorn University

Chula Pharmacy prepares to test “Baiya Vaccine” a Thai vaccine against COVID–19 by “Baiya Phytofarm“, a Chula startup. The vaccines have been produced at the first plant in Asia that manufactures plant–based vaccines for humans. Clinical trials with volunteers and the research for the second–generation vaccine to fight the virus variants are to commence in September 2021.


Showing results

110 of 6075

close
1.74106